Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT.

Osborn D, Burton A, Walters K, Atkins L, Barnes T, Blackburn R, Craig T, Gilbert H, Gray B, Hardoon S, Heinkel S, Holt R, Hunter R, Johnston C, King M, Leibowitz J, Marston L, Michie S, Morris R, Morris S, Nazareth I, Omar R, Petersen I, Peveler R, Pinfold V, Stevenson F, Zomer E.

Southampton (UK): NIHR Journals Library; 2019 Apr.

2.

Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial.

Osborn D, Burton A, Hunter R, Marston L, Atkins L, Barnes T, Blackburn R, Craig T, Gilbert H, Heinkel S, Holt R, King M, Michie S, Morris R, Morris S, Nazareth I, Omar R, Petersen I, Peveler R, Pinfold V, Walters K.

Lancet Psychiatry. 2018 Feb;5(2):145-154. doi: 10.1016/S2215-0366(18)30007-5. Epub 2018 Jan 22. Erratum in: Lancet Psychiatry. 2019 Jan;6(1):e2.

3.

Evaluating the clinical and cost effectiveness of a behaviour change intervention for lowering cardiovascular disease risk for people with severe mental illnesses in primary care (PRIMROSE study): study protocol for a cluster randomised controlled trial.

Osborn D, Burton A, Walters K, Nazareth I, Heinkel S, Atkins L, Blackburn R, Holt R, Hunter R, King M, Marston L, Michie S, Morris R, Morris S, Omar R, Peveler R, Pinfold V, Zomer E, Barnes T, Craig T, Gilbert H, Grey B, Johnston C, Leibowitz J, Petersen I, Stevenson F, Hardy S, Robinson V.

Trials. 2016 Feb 12;17:80. doi: 10.1186/s13063-016-1176-9.

4.

Quality of Life in Depressed Patients in UK Primary Care: The FINDER Study.

Lenox-Smith A, Macdonald MT, Reed C, Tylee A, Peveler R, Quail D, Wildgust HJ.

Neurol Ther. 2013 Mar 13;2(1-2):25-42. doi: 10.1007/s40120-013-0006-1. eCollection 2013 Dec.

5.

Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.

Barnard K, Peveler RC, Holt RI.

Diabetes Care. 2013 Oct;36(10):3337-45. doi: 10.2337/dc13-0560. Review.

6.

The relationship between depression, anxiety and cardiovascular disease: findings from the Hertfordshire Cohort Study.

Holt RI, Phillips DI, Jameson KA, Cooper C, Dennison EM, Peveler RC; Hertfordshire Cohort Study Group.

J Affect Disord. 2013 Aug 15;150(1):84-90. doi: 10.1016/j.jad.2013.02.026. Epub 2013 Mar 15.

7.

A psychometric evaluation of an English version of the Utrecht Coping List.

Turner H, Bryant-Waugh R, Peveler R, Bucks RS.

Eur Eat Disord Rev. 2012 Jul;20(4):339-42. doi: 10.1002/erv.2173. Epub 2012 Mar 14.

PMID:
22419565
8.

When a minor head injury results in enduring symptoms: a prospective investigation of risk factors for postconcussional syndrome after mild traumatic brain injury.

Hou R, Moss-Morris R, Peveler R, Mogg K, Bradley BP, Belli A.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):217-23. doi: 10.1136/jnnp-2011-300767. Epub 2011 Oct 25.

PMID:
22028384
9.

External eating, impulsivity and attentional bias to food cues.

Hou R, Mogg K, Bradley BP, Moss-Morris R, Peveler R, Roefs A.

Appetite. 2011 Apr;56(2):424-7. doi: 10.1016/j.appet.2011.01.019. Epub 2011 Jan 21.

PMID:
21256908
10.

Guidelines for the management of depression: NICE work?

Kendrick T, Peveler R.

Br J Psychiatry. 2010 Nov;197(5):345-7. doi: 10.1192/bjp.bp.109.074575.

PMID:
21037209
11.

Relationship between loneliness and proangiogenic cytokines in newly diagnosed tumors of colon and rectum.

Nausheen B, Carr NJ, Peveler RC, Moss-Morris R, Verrill C, Robbins E, Nugent KP, Baker AM, Judd M, Gidron Y.

Psychosom Med. 2010 Nov;72(9):912-6. doi: 10.1097/PSY.0b013e3181f0bc1c. Epub 2010 Aug 17.

PMID:
20716709
12.

Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.

Holt RI, Peveler RC.

Clin Endocrinol (Oxf). 2011 Feb;74(2):141-7. doi: 10.1111/j.1365-2265.2010.03814.x. Review.

PMID:
20455888
13.

Estimating probability of sustained recovery from mild to moderate depression in primary care: evidence from the THREAD study.

Dowrick C, Flach C, Leese M, Chatwin J, Morriss R, Peveler R, Gabbay M, Byng R, Moore M, Tylee A, Kendrick T; THREAD Study Group.

Psychol Med. 2011 Jan;41(1):141-50. doi: 10.1017/S0033291710000437. Epub 2010 Mar 29.

PMID:
20346195
14.

The clinical features of EDNOS: relationship to mood, health status and general functioning.

Turner H, Bryant-Waugh R, Peveler R.

Eat Behav. 2010 Apr;11(2):127-30. doi: 10.1016/j.eatbeh.2009.10.006. Epub 2009 Nov 1.

PMID:
20188298
15.

A new approach to clustering eating disorder patients: assessing external validity and comparisons with DSM-IV diagnoses.

Turner H, Bryant-Waugh R, Peveler R.

Eat Behav. 2010 Apr;11(2):99-106. doi: 10.1016/j.eatbeh.2009.10.005. Epub 2009 Nov 4.

PMID:
20188293
16.

Do treatment and illness beliefs influence adherence to medication in patients with bipolar affective disorder? A preliminary cross-sectional study.

Hou R, Cleak V, Peveler R.

Eur Psychiatry. 2010 May;25(4):216-9. doi: 10.1016/j.eurpsy.2009.09.003. Epub 2009 Dec 14.

PMID:
20005683
17.

Social support and cancer progression: a systematic review.

Nausheen B, Gidron Y, Peveler R, Moss-Morris R.

J Psychosom Res. 2009 Nov;67(5):403-15. doi: 10.1016/j.jpsychores.2008.12.012. Epub 2009 Mar 3. Review.

PMID:
19837203
18.

The relationship between depression and diabetes mellitus: findings from the Hertfordshire Cohort Study.

Holt RI, Phillips DI, Jameson KA, Cooper C, Dennison EM, Peveler RC; Hertfordshire Cohort Study Group.

Diabet Med. 2009 Jun;26(6):641-8. doi: 10.1111/j.1464-5491.2009.02742.x.

PMID:
19538241
19.

Obesity, serious mental illness and antipsychotic drugs.

Holt RI, Peveler RC.

Diabetes Obes Metab. 2009 Jul;11(7):665-79. doi: 10.1111/j.1463-1326.2009.01038.x. Epub 2009 May 19. Review.

PMID:
19476478
20.

Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.

Kendrick T, Chatwin J, Dowrick C, Tylee A, Morriss R, Peveler R, Leese M, McCrone P, Harris T, Moore M, Byng R, Brown G, Barthel S, Mander H, Ring A, Kelly V, Wallace V, Gabbay M, Craig T, Mann A.

Health Technol Assess. 2009 Apr;13(22):iii-iv, ix-xi, 1-159. doi: 10.3310/hta13220.

21.

An approach to sub-grouping the eating disorder population: adding attachment and coping style.

Turner H, Bryant-Waugh R, Peveler R.

Eur Eat Disord Rev. 2009 Jul;17(4):269-80. doi: 10.1002/erv.931.

PMID:
19378348
22.

The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness.

Holt RI, Abdelrahman T, Hirsch M, Dhesi Z, George T, Blincoe T, Peveler RC.

J Psychopharmacol. 2010 Jun;24(6):867-73. doi: 10.1177/0269881109102788. Epub 2009 Mar 20.

PMID:
19304868
23.

The effect of concurrent pain on the management of patients with depression: an analysis of NHS healthcare resource utilisation using the GPRD database.

Watson L, Baird J, Hösel V, Peveler R.

Int J Clin Pract. 2009 May;63(5):698-706. doi: 10.1111/j.1742-1241.2009.02017.x. Epub 2009 Feb 24.

PMID:
19243454
24.

Antipsychotics and hyperprolactinaemia: clinical recommendations.

Peveler RC, Branford D, Citrome L, Fitzgerald P, Harvey PW, Holt RI, Howard L, Kohen D, Jones I, O'Keane V, Pariente CM, Pendlebury J, Smith SM, Yeomans D.

J Psychopharmacol. 2008 Mar;22(2 Suppl):98-103. doi: 10.1177/0269881107087346. Review.

PMID:
18477626
25.

A review of the association between antipsychotic use and hyperprolactinaemia.

Bushe C, Shaw M, Peveler RC.

J Psychopharmacol. 2008 Mar;22(2 Suppl):46-55. doi: 10.1177/0269881107088435. Review.

PMID:
18477620
26.

Attentional bias towards health-threat information in chronic fatigue syndrome.

Hou R, Moss-Morris R, Bradley BP, Peveler R, Mogg K.

J Psychosom Res. 2008 Jul;65(1):47-50. doi: 10.1016/j.jpsychores.2008.03.008.

PMID:
18582611
27.

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis.

Smith M, Hopkins D, Peveler RC, Holt RI, Woodward M, Ismail K.

Br J Psychiatry. 2008 Jun;192(6):406-11. doi: 10.1192/bjp.bp.107.037184. Review.

PMID:
18515889
28.

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.

Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A.

J Psychopharmacol. 2008 Jun;22(4):343-96. doi: 10.1177/0269881107088441. Epub 2008 Apr 15.

PMID:
18413657
29.

Qualitative study of depression management in primary care: GP and patient goals, and the value of listening.

Johnston O, Kumar S, Kendall K, Peveler R, Gabbay J, Kendrick T.

Br J Gen Pract. 2007 Nov;57(544):872-9.

30.

A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression.

Perahia DG, Quail D, Gandhi P, Walker DJ, Peveler RC.

J Affect Disord. 2008 May;108(1-2):33-41. Epub 2007 Oct 1.

PMID:
17905442
31.

Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.

Barnett AH, Mackin P, Chaudhry I, Farooqi A, Gadsby R, Heald A, Hill J, Millar H, Peveler R, Rees A, Singh V, Taylor D, Vora J, Jones PB.

J Psychopharmacol. 2007 Jun;21(4):357-73. Review. Erratum in: J Psychopharmacol. 2008 Aug;22(6):699.

PMID:
17656425
32.

Acute symptoms following work with pesticides.

Solomon C, Poole J, Palmer KT, Peveler R, Coggon D.

Occup Med (Lond). 2007 Oct;57(7):505-11. Epub 2007 Jul 25.

33.

Loneliness, social support and cardiovascular reactivity to laboratory stress.

Nausheen B, Gidron Y, Gregg A, Tissarchondou HS, Peveler R.

Stress. 2007 Mar;10(1):37-44.

PMID:
17454965
34.

Pain tolerance in patients presenting to primary care and physiotherapy services with upper limb disorders.

Ryall C, Coggon D, Peveler R, Reading I, Palmer KT.

Occup Environ Med. 2007 May;64(5):349-51. Epub 2006 Dec 20.

35.

Neuropsychiatric symptoms in past users of sheep dip and other pesticides.

Solomon C, Poole J, Palmer KT, Peveler R, Coggon D.

Occup Environ Med. 2007 Apr;64(4):259-66. Epub 2006 Nov 9.

36.

A prospective cohort study of arm pain in primary care and physiotherapy--prognostic determinants.

Ryall C, Coggon D, Peveler R, Poole J, Palmer KT.

Rheumatology (Oxford). 2007 Mar;46(3):508-15. Epub 2006 Sep 14.

PMID:
16973688
37.

Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs.

Jones RM, Butler JA, Thomas VA, Peveler RC, Prevett M.

Seizure. 2006 Oct;15(7):504-8. Epub 2006 Jul 24.

38.

The association of depression and painful physical symptoms--a review of the European literature.

Garcia-Cebrian A, Gandhi P, Demyttenaere K, Peveler R.

Eur Psychiatry. 2006 Sep;21(6):379-88. Epub 2006 Jun 23. Review.

PMID:
16797937
39.

Antipsychotic drugs and diabetes--an application of the Austin Bradford Hill criteria.

Holt RI, Peveler RC.

Diabetologia. 2006 Jul;49(7):1467-76. Epub 2006 May 13. Review.

PMID:
16752165
40.

The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review.

Barnard KD, Skinner TC, Peveler R.

Diabet Med. 2006 Apr;23(4):445-8. Review.

PMID:
16620276
41.

Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial.

Kendrick T, Peveler R, Longworth L, Baldwin D, Moore M, Chatwin J, Thornett A, Goddard J, Campbell M, Smith H, Buxton M, Thompson C.

Br J Psychiatry. 2006 Apr;188:337-45.

PMID:
16582060
42.

Painful symptoms in depression: under-recognised and under-treated?

Peveler R, Katona C, Wessely S, Dowrick C.

Br J Psychiatry. 2006 Mar;188:202-3.

PMID:
16507958
43.

A case-control study of risk factors for arm pain presenting to primary care services.

Ryall C, Coggon D, Peveler R, Reading I, Palmer KT.

Occup Med (Lond). 2006 Mar;56(2):137-43. Epub 2006 Feb 1.

PMID:
16452130
44.

Association between antipsychotic drugs and diabetes.

Holt RI, Peveler RC.

Diabetes Obes Metab. 2006 Mar;8(2):125-35. Review.

PMID:
16448516
45.

Somatic symptoms and depression: diagnostic confusion and clinical neglect.

Dowrick C, Katona C, Peveler R, Lloyd H.

Br J Gen Pract. 2005 Nov;55(520):829-30. No abstract available.

46.

The role of lifestyle interventions and weight management in schizophrenia.

Bushe C, Haddad P, Peveler R, Pendlebury J.

J Psychopharmacol. 2005 Nov;19(6 Suppl):28-35. Review.

PMID:
16280335
47.

Pain symptoms in depression: definition and clinical significance.

Katona C, Peveler R, Dowrick C, Wessely S, Feinmann C, Gask L, Lloyd H, Williams AC, Wager E.

Clin Med (Lond). 2005 Jul-Aug;5(4):390-5. Review.

48.

Comparison of general practitioner records and patient self-report questionnaires for estimation of costs.

Mistry H, Buxton M, Longworth L, Chatwin J, Peveler R; Assessing Health Economics of Antidepressants Team.

Eur J Health Econ. 2005 Sep;6(3):261-6.

PMID:
15968562
49.

A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.

Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, Chatwin J, Goddard J, Thornett A, Smith H, Campbell M, Thompson C.

Health Technol Assess. 2005 May;9(16):1-134, iii.

50.

Selective serotonin reuptake inhibitors: THREAD trial may show way forward.

Peveler R, Kendrick T; THREAD Study Group.

BMJ. 2005 Feb 19;330(7488):420-1. No abstract available.

Supplemental Content

Loading ...
Support Center